Click to see the modal popup.

FY 2012 Grant Request for Applications (RFA)

PPHF-2012-Cooperative Agreements for Prescription Drug Monitoring Program (PDMP) Electronic Health Record (EHR) Integration and Interoperability Expansion (PPHF-2012) (Short Title: PDMP EHR Integration and Interoperability)


Request for Applications (RFA) No.: TI-12-011
Posting on June 29, 2012
Original Receipt date: July 31, 2012

Catalogue of Federal Domestic Assistance (CFDA) No.: 93.748

Key Dates

Application Deadline Applications are due by July 31, 2012

The Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment is accepting applications for fiscal year (FY) 2012 PPHF-2012-Cooperative Agreements for Prescription Drug Monitoring Program (PDMP) Electronic Health Record (EHR) Integration and Interoperability Expansion (PPHF-2012). The purpose of this program is to: 1) improve real-time access to PDMP data by integrating PDMPs into existing technologies like EHRs, in order to improve the ability of State PDMPs to reduce the nature, scope, and extent of prescription drug abuse; and 2) strengthen State PDMPs that are currently operational by providing resources to make the changes necessary to increase interoperability of State PDMPs. Grant funds will enable States to integrate their PDMPs into EHR and other health information technology systems to expand utilization of PDMP data by increasing the production and distribution of unsolicited reports and alerts to prescribers and dispensers of prescription data. Grant funds will also be used by States to allow for modification of their systems to expand interoperability. This grant program will be complemented by an evaluation program conducted by the Centers for Disease Control and Prevention (CDC).

A Federal Expanded Interoperability and EHR Integration program is expected to produce immediate and measurable outcomes in the number of States that are able to share information. In addition, resources to States to enable their PDMPs to link electronically to Emergency Department EHRs, outpatient facility EHRs, and retail pharmacy chain dispensing systems hold the possibility to expand utilization dramatically. CDC will systematically evaluate how both measures have affected prescription drug abuse and utilization of PDMPs.

The Centers for Disease Control and Prevention (CDC) Injury Center’s prescription drug overdose team will develop metrics that are consistent across the States to ensure a robust and systematic evaluation and identify appropriate data sources to support the evaluation.


Eligible applicants are the immediate office of the Chief Executive (e.g., Governor) in the 49 States and 1 U.S. territory (i.e., Guam) that have enacted legislation or regulations that permit the following:

  • Implementation of a State PDMP;
  • Imposition of appropriate penalties for the unauthorized use and disclosure of information maintained in the program; and
  • Ability to share PDMP data (de-identified or anonymized) with CDC for evaluation purposes.

Eligibility is limited to States/Territory with enacted PDMP legislation because only these States/Territory have the capability to collect the required information and make that information available to prescribers, dispensers, and under controls, other States. PDMPs that are not actively collecting information cannot link their systems to EHRs or share information with other State PMDPs. Due to State laws establishing PDMPs, privacy, confidentiality, security, and other limitations on PDMPs, PDMP EHR Integration and Interoperability grants are limited to State and applicable territorial government entities.

Award Information

Funding Mechanism: Cooperative Agreements
Anticipated Total Available Funding: $3.6 million
Anticipated Number of Awards: Up to 8
Anticipated Award Amount: Up to $225,000 per year
Length of Project Period: Up to 2 years

Proposed budgets cannot exceed $225,000 in total costs (direct and indirect) in each year of the proposed two-year project. Multi-year funding will depend on grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award. This program is financed by 2012 Prevention and Public Health Funds (PPHF-2012).

These awards will be made as Cooperative Agreements

Contact Information

For questions about program issues contact:

Jinhee J. Lee, Pharm.D.
Project Officer
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road
Room 7 -1028
Rockville, Maryland 20857
(240) 276-0545

For questions on grants management and budget issues contact:

Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
1 Choke Cherry Road
Room 7-1095
Rockville, Maryland 20857
(240) 276-1412

Documents Needed to Complete a Grant Application





Additional Materials

For further information on the forms and the application process, see Useful Information for Applicants.

Additional materials available on this website include:


Last updated: 06/28/2012